Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease.
Identifieur interne : 000568 ( PubMed/Curation ); précédent : 000567; suivant : 000569Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease.
Auteurs : Leigh Christopher [Canada] ; Sarah Duff-Canning ; Yuko Koshimori ; Barbara Segura ; Isabelle Boileau ; Robert Chen ; Anthony E. Lang ; Sylvain Houle ; Pablo Rusjan ; Antonio P. StrafellaSource :
- Annals of neurology [ 1531-8249 ] ; 2015.
English descriptors
- KwdEn :
- Aged, Dopamine (metabolism), Dopaminergic Neurons (diagnostic imaging), Dopaminergic Neurons (metabolism), Female, Humans, Male, Memory Disorders (diagnostic imaging), Memory Disorders (metabolism), Middle Aged, Nerve Net (diagnostic imaging), Nerve Net (metabolism), Parahippocampal Gyrus (diagnostic imaging), Parahippocampal Gyrus (metabolism), Parkinson Disease (diagnostic imaging), Parkinson Disease (metabolism), Positron-Emission Tomography (methods), Protein Binding (physiology), Receptors, Dopamine D2 (metabolism).
- MESH :
- chemical , metabolism : Dopamine, Receptors, Dopamine D2.
- diagnostic imaging : Dopaminergic Neurons, Memory Disorders, Nerve Net, Parahippocampal Gyrus, Parkinson Disease.
- metabolism : Dopaminergic Neurons, Memory Disorders, Nerve Net, Parahippocampal Gyrus, Parkinson Disease.
- methods : Positron-Emission Tomography.
- physiology : Protein Binding.
- Aged, Female, Humans, Male, Middle Aged.
Abstract
Patients with Parkinson disease (PD) and mild cognitive impairment (MCI) are vulnerable to dementia and frequently experience memory deficits. This could be the result of dopamine dysfunction in corticostriatal networks (salience, central executive networks, and striatum) and/or the medial temporal lobe. Our aim was to investigate whether dopamine dysfunction in these regions contributes to memory impairment in PD.
DOI: 10.1002/ana.24323
PubMed: 25448687
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000568
Links to Exploration step
pubmed:25448687Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease.</title><author><name sortKey="Christopher, Leigh" sort="Christopher, Leigh" uniqKey="Christopher L" first="Leigh" last="Christopher">Leigh Christopher</name><affiliation wicri:level="1"><nlm:affiliation>Morton and Gloria Shulman Movement Disorder Unit and Edmond J. Safra Program in Parkinson Disease, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada; Division of Brain, Imaging, and Behaviour-Systems Neuroscience, Toronto Western Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Morton and Gloria Shulman Movement Disorder Unit and Edmond J. Safra Program in Parkinson Disease, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada; Division of Brain, Imaging, and Behaviour-Systems Neuroscience, Toronto Western Research Institute, University Health Network, University of Toronto, Toronto, Ontario</wicri:regionArea></affiliation></author><author><name sortKey="Duff Canning, Sarah" sort="Duff Canning, Sarah" uniqKey="Duff Canning S" first="Sarah" last="Duff-Canning">Sarah Duff-Canning</name></author><author><name sortKey="Koshimori, Yuko" sort="Koshimori, Yuko" uniqKey="Koshimori Y" first="Yuko" last="Koshimori">Yuko Koshimori</name></author><author><name sortKey="Segura, Barbara" sort="Segura, Barbara" uniqKey="Segura B" first="Barbara" last="Segura">Barbara Segura</name></author><author><name sortKey="Boileau, Isabelle" sort="Boileau, Isabelle" uniqKey="Boileau I" first="Isabelle" last="Boileau">Isabelle Boileau</name></author><author><name sortKey="Chen, Robert" sort="Chen, Robert" uniqKey="Chen R" first="Robert" last="Chen">Robert Chen</name></author><author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name></author><author><name sortKey="Houle, Sylvain" sort="Houle, Sylvain" uniqKey="Houle S" first="Sylvain" last="Houle">Sylvain Houle</name></author><author><name sortKey="Rusjan, Pablo" sort="Rusjan, Pablo" uniqKey="Rusjan P" first="Pablo" last="Rusjan">Pablo Rusjan</name></author><author><name sortKey="Strafella, Antonio P" sort="Strafella, Antonio P" uniqKey="Strafella A" first="Antonio P" last="Strafella">Antonio P. Strafella</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25448687</idno><idno type="pmid">25448687</idno><idno type="doi">10.1002/ana.24323</idno><idno type="wicri:Area/PubMed/Corpus">000568</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000568</idno><idno type="wicri:Area/PubMed/Curation">000568</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000568</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease.</title><author><name sortKey="Christopher, Leigh" sort="Christopher, Leigh" uniqKey="Christopher L" first="Leigh" last="Christopher">Leigh Christopher</name><affiliation wicri:level="1"><nlm:affiliation>Morton and Gloria Shulman Movement Disorder Unit and Edmond J. Safra Program in Parkinson Disease, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada; Division of Brain, Imaging, and Behaviour-Systems Neuroscience, Toronto Western Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Morton and Gloria Shulman Movement Disorder Unit and Edmond J. Safra Program in Parkinson Disease, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada; Division of Brain, Imaging, and Behaviour-Systems Neuroscience, Toronto Western Research Institute, University Health Network, University of Toronto, Toronto, Ontario</wicri:regionArea></affiliation></author><author><name sortKey="Duff Canning, Sarah" sort="Duff Canning, Sarah" uniqKey="Duff Canning S" first="Sarah" last="Duff-Canning">Sarah Duff-Canning</name></author><author><name sortKey="Koshimori, Yuko" sort="Koshimori, Yuko" uniqKey="Koshimori Y" first="Yuko" last="Koshimori">Yuko Koshimori</name></author><author><name sortKey="Segura, Barbara" sort="Segura, Barbara" uniqKey="Segura B" first="Barbara" last="Segura">Barbara Segura</name></author><author><name sortKey="Boileau, Isabelle" sort="Boileau, Isabelle" uniqKey="Boileau I" first="Isabelle" last="Boileau">Isabelle Boileau</name></author><author><name sortKey="Chen, Robert" sort="Chen, Robert" uniqKey="Chen R" first="Robert" last="Chen">Robert Chen</name></author><author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name></author><author><name sortKey="Houle, Sylvain" sort="Houle, Sylvain" uniqKey="Houle S" first="Sylvain" last="Houle">Sylvain Houle</name></author><author><name sortKey="Rusjan, Pablo" sort="Rusjan, Pablo" uniqKey="Rusjan P" first="Pablo" last="Rusjan">Pablo Rusjan</name></author><author><name sortKey="Strafella, Antonio P" sort="Strafella, Antonio P" uniqKey="Strafella A" first="Antonio P" last="Strafella">Antonio P. Strafella</name></author></analytic><series><title level="j">Annals of neurology</title><idno type="eISSN">1531-8249</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Dopamine (metabolism)</term><term>Dopaminergic Neurons (diagnostic imaging)</term><term>Dopaminergic Neurons (metabolism)</term><term>Female</term><term>Humans</term><term>Male</term><term>Memory Disorders (diagnostic imaging)</term><term>Memory Disorders (metabolism)</term><term>Middle Aged</term><term>Nerve Net (diagnostic imaging)</term><term>Nerve Net (metabolism)</term><term>Parahippocampal Gyrus (diagnostic imaging)</term><term>Parahippocampal Gyrus (metabolism)</term><term>Parkinson Disease (diagnostic imaging)</term><term>Parkinson Disease (metabolism)</term><term>Positron-Emission Tomography (methods)</term><term>Protein Binding (physiology)</term><term>Receptors, Dopamine D2 (metabolism)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Dopamine</term><term>Receptors, Dopamine D2</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Dopaminergic Neurons</term><term>Memory Disorders</term><term>Nerve Net</term><term>Parahippocampal Gyrus</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Dopaminergic Neurons</term><term>Memory Disorders</term><term>Nerve Net</term><term>Parahippocampal Gyrus</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Positron-Emission Tomography</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Protein Binding</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Patients with Parkinson disease (PD) and mild cognitive impairment (MCI) are vulnerable to dementia and frequently experience memory deficits. This could be the result of dopamine dysfunction in corticostriatal networks (salience, central executive networks, and striatum) and/or the medial temporal lobe. Our aim was to investigate whether dopamine dysfunction in these regions contributes to memory impairment in PD.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25448687</PMID><DateCreated><Year>2015</Year><Month>02</Month><Day>03</Day></DateCreated><DateCompleted><Year>2015</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8249</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Annals of neurology</Title><ISOAbbreviation>Ann. Neurol.</ISOAbbreviation></Journal><ArticleTitle>Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease.</ArticleTitle><Pagination><MedlinePgn>269-80</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ana.24323</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Patients with Parkinson disease (PD) and mild cognitive impairment (MCI) are vulnerable to dementia and frequently experience memory deficits. This could be the result of dopamine dysfunction in corticostriatal networks (salience, central executive networks, and striatum) and/or the medial temporal lobe. Our aim was to investigate whether dopamine dysfunction in these regions contributes to memory impairment in PD.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used positron emission tomography imaging to compare D2 receptor availability in the cortex and striatal (limbic and associative) dopamine neuron integrity in 4 groups: memory-impaired PD (amnestic MCI; n = 9), PD with nonamnestic MCI (n = 10), PD without MCI (n = 11), and healthy controls (n = 14). Subjects were administered a full neuropsychological test battery for cognitive performance.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Memory-impaired patients demonstrated more significant reductions in D2 receptor binding in the salience network (insular cortex and anterior cingulate cortex [ACC] and the right parahippocampal gyrus [PHG]) compared to healthy controls and patients with no MCI. They also presented reductions in the right insula and right ACC compared to nonamnestic MCI patients. D2 levels were correlated with memory performance in the right PHG and left insula of amnestic patients and with executive performance in the bilateral insula and left ACC of all MCI patients. Associative striatal dopamine denervation was significant in all PD patients.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Dopaminergic differences in the salience network and the medial temporal lobe contribute to memory impairment in PD. Furthermore, these findings indicate the vulnerability of the salience network in PD and its potential role in memory and executive dysfunction.</AbstractText><CopyrightInformation>© 2014 American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Christopher</LastName><ForeName>Leigh</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Morton and Gloria Shulman Movement Disorder Unit and Edmond J. Safra Program in Parkinson Disease, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada; Division of Brain, Imaging, and Behaviour-Systems Neuroscience, Toronto Western Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duff-Canning</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Koshimori</LastName><ForeName>Yuko</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Segura</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Boileau</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Lang</LastName><ForeName>Anthony E</ForeName><Initials>AE</Initials></Author><Author ValidYN="Y"><LastName>Houle</LastName><ForeName>Sylvain</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Rusjan</LastName><ForeName>Pablo</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Strafella</LastName><ForeName>Antonio P</ForeName><Initials>AP</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>110962-1</GrantID><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant><Grant><GrantID>MOP 110962</GrantID><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Neurol</MedlineTA><NlmUniqueID>7707449</NlmUniqueID><ISSNLinking>0364-5134</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017448">Receptors, Dopamine D2</NameOfSubstance></Chemical><Chemical><RegistryNumber>VTD58H1Z2X</RegistryNumber><NameOfSubstance UI="D004298">Dopamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Neurochem. 1988 Apr;50(4):1131-6</RefSource><PMID Version="1">3346671</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychopharmacology. 2013 Nov;38(12):2409-17</RefSource><PMID Version="1">23728140</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cereb Blood Flow Metab. 2001 Sep;21(9):1034-57</RefSource><PMID Version="1">11524609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychology. 2011 Jan;25(1):114-24</RefSource><PMID Version="1">20954781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2005 Jun 2;46(5):703-13</RefSource><PMID Version="1">15924857</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroimage. 2000 Sep;12 (3):245-56</RefSource><PMID Version="1">10944407</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nature. 2001 Mar 15;410(6826):366-9</RefSource><PMID Version="1">11268212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2007 Nov;130(Pt 11):2837-44</RefSource><PMID Version="1">17928318</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 2014 Aug;76(2):241-51</RefSource><PMID Version="1">24933580</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroimage. 1999 Feb;9(2):195-207</RefSource><PMID Version="1">9931269</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychiatry Res. 2006 Jun 30;147(1):79-89</RefSource><PMID Version="1">16797168</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12569-74</RefSource><PMID Version="1">18723676</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neural Transm (Vienna). 2003 Jun;110(6):591-601</RefSource><PMID Version="1">12768355</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2007 Sep 15;22(12):1689-707; quiz 1837</RefSource><PMID Version="1">17542011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2012 Jun;135(Pt 6):1884-99</RefSource><PMID Version="1">22561640</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cogn Sci. 2002 Jul 1;6(7):299-305</RefSource><PMID Version="1">12110363</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2002 Aug 29;35(5):989-96</RefSource><PMID Version="1">12372291</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Comput Assist Tomogr. 1994 Mar-Apr;18(2):192-205</RefSource><PMID Version="1">8126267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 2008 Mar;63(3):388-94</RefSource><PMID Version="1">18240153</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Exp Neuropsychol. 2004 May;26(3):347-55</RefSource><PMID Version="1">15512925</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Nucl Med. 1998 May;39(5):904-11</RefSource><PMID Version="1">9591599</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cogn Neurosci. 1996 Nov;8(6):588-602</RefSource><PMID Version="1">23961986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2006 Dec;21(12):2042-51</RefSource><PMID Version="1">17078043</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2006 Jan 18;26(3):916-25</RefSource><PMID Version="1">16421311</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cereb Blood Flow Metab. 2006 Sep;26(9):1198-212</RefSource><PMID Version="1">16421508</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>IEEE Trans Med Imaging. 1997 Apr;16(2):145-58</RefSource><PMID Version="1">9101324</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Gen Psychiatry. 1961 Jun;4:561-71</RefSource><PMID Version="1">13688369</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2004 Apr;19(4):397-405</RefSource><PMID Version="1">15077237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1998 Aug 21;281(5380):1188-91</RefSource><PMID Version="1">9712582</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA Neurol. 2013 May;70(5):580-6</RefSource><PMID Version="1">23529397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):4690-5</RefSource><PMID Version="1">22393019</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroimage. 1996 Dec;4(3 Pt 1):153-8</RefSource><PMID Version="1">9345505</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 1997 Dec 15;17(24):9686-705</RefSource><PMID Version="1">9391023</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurotherapeutics. 2011 Jan;8(1):72-81</RefSource><PMID Version="1">21274687</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2010 Feb 25;65(4):550-62</RefSource><PMID Version="1">20188659</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 2006;44(10):1663-73</RefSource><PMID Version="1">16730032</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Brain Mapp. 2014 Mar;35(3):1061-73</RefSource><PMID Version="1">23404748</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2002 Nov;17(6):1221-6</RefSource><PMID Version="1">12465060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2007 Feb 28;27(9):2349-56</RefSource><PMID Version="1">17329432</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroimage. 2010 Apr 1;50(2):734-41</RefSource><PMID Version="1">20045475</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 1989;27(8):1073-9</RefSource><PMID Version="1">2797414</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Neurol. 2013 Aug;12(8):811-21</RefSource><PMID Version="1">23867199</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurobiol Dis. 2010 Feb;37(2):477-82</RefSource><PMID Version="1">19914378</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2013 Jun;136(Pt 6):1929-41</RefSource><PMID Version="1">23576128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroimage. 1997 Nov;6(4):279-87</RefSource><PMID Version="1">9417971</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2012 Mar;27(3):349-56</RefSource><PMID Version="1">22275317</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cogn Sci. 2007 Sep;11(9):379-86</RefSource><PMID Version="1">17707683</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuron. 2009 Apr 16;62(1):42-52</RefSource><PMID Version="1">19376066</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 1998 Nov;36(11):1217-38</RefSource><PMID Version="1">9842767</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cereb Blood Flow Metab. 1996 Nov;16(6):1288-99</RefSource><PMID Version="1">8898703</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 1996 Dec;40(6):873-84</RefSource><PMID Version="1">9007092</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cogn Sci. 2009 Aug;13(8):334-40</RefSource><PMID Version="1">19643659</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11050-5</RefSource><PMID Version="1">10984517</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Neurosci. 1990 Jul;13(7):266-71</RefSource><PMID Version="1">1695401</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2181-6</RefSource><PMID Version="1">18238903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2008 Sep 24;28(39):9850-6</RefSource><PMID Version="1">18815269</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuroimage. 1999 Feb;9(2):179-94</RefSource><PMID Version="1">9931268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011 Apr 11;6(4):e17463</RefSource><PMID Version="1">21494597</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cogn Sci. 2005 Sep;9(9):445-53</RefSource><PMID Version="1">16054861</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Comput Assist Tomogr. 1993 Jul-Aug;17 (4):536-46</RefSource><PMID Version="1">8331222</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2014 Feb;137(Pt 2):565-75</RefSource><PMID Version="1">24334314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Struct Funct. 2010 Jun;214(5-6):655-67</RefSource><PMID Version="1">20512370</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain Cogn. 1990 Jul;13(2):211-32</RefSource><PMID Version="1">2390235</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2013 Jan 1;80(1):85-91</RefSource><PMID Version="1">23243071</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prog Neurobiol. 2004 Sep;74(1):1-58</RefSource><PMID Version="1">15381316</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2000 Sep 15;20(18):7067-73</RefSource><PMID Version="1">10995853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 1992 Apr;30(4):301-14</RefSource><PMID Version="1">1603295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trends Cogn Sci. 2010 Oct;14(10):464-72</RefSource><PMID Version="1">20829095</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Nucl Med. 1999 Feb;40(2):283-9</RefSource><PMID Version="1">10025836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2007 Mar;78(3):254-9</RefSource><PMID Version="1">17028119</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059290" MajorTopicYN="N">Dopaminergic Neurons</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009415" MajorTopicYN="N">Nerve Net</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020534" MajorTopicYN="N">Parahippocampal Gyrus</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017448" MajorTopicYN="N">Receptors, Dopamine D2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><OtherID Source="NLM">CAMS4633</OtherID><OtherID Source="NLM">PMC4874785</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>06</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>11</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25448687</ArticleId><ArticleId IdType="doi">10.1002/ana.24323</ArticleId><ArticleId IdType="pmc">PMC4874785</ArticleId><ArticleId IdType="mid">CAMS4633</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000568 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000568 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:25448687
|texte= Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25448687" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |